Wanjia Group Holdings Limited (HKG:0401)

Wanjia Group Holdings Revenue

In the fiscal year ending March 31, 2026, Wanjia Group Holdings had annual revenue of 165.39M HKD with 2.28% growth. Wanjia Group Holdings had revenue of 79.68M in the half year ending March 31, 2026, a decrease of -9.17%. That makes Wanjia Group Holdings the 33,505th largest company in the world by revenue and 2,019th in Hong Kong.

• Revenue: 165.39M
• Revenue Growth: +2.28%
• P/S Ratio: 0.69
• Revenue / Employee: 903.74K
• Employees: 183
• Market Cap: 113.99M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Hemodialysis Treatment and Consultancy Service Business 110.06M 66.6%
• Pharmaceutical Wholesale and Distribution Business 55.32M 33.4%

Fiscal year ended Mar 31, 2026 See the full Wanjia Group Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	165.39M	3.69M	2.28%
Mar 31, 2025	161.69M	-19.40M	-10.71%
Mar 31, 2024	181.09M	7.39M	4.25%
Mar 31, 2023	173.70M	18.88M	12.19%
Mar 31, 2022	154.82M	40.74M	35.71%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error